Stéphane Bancel believes there's about an 80% chance that the virus causing COVID-19 will get less virulent, but cautioned it remains "unpredictable."
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expectations of $104 billion.
Even the CEOs of Pfizer and Moderna, who were leaning toward fourth doses, have eased off their rhetoric. The data just isn't there, scientists say.
Moderna CEO Stéphane Bancel previously projected the Omicron-specific vaccine booster to be available as early as this fall.
The huge new CDC dataset backs up what other studies have found, that Moderna is edging out Pfizer and J&J is offering less protection against COVID.
People who develop multiple sclerosis were often previously infected with EBV, the mononucleosis virus, according to new research.
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld a mandate for healthcare workers.
The latest estimates from the CDC say the Omicron variant accounts for about 95% of all current COVID-19 cases in the US.
Popular exchange-traded funds like Invesco's QQQ also made the list, according to the Nasdaq Retail Trading Activity Tracker.
Boosters will likely protect people through the current Omicron surge, Moderna's Stephane Bancel said. But their efficacy will probably wane in the months ahead.
Experts said boosters should still provide protection against hospitalization and death from COVID-19 caused by Omicron.
Suzie Glassman, 44, says she had a sore arm for about 24 hours and chills and body aches overnight after getting the Moderna booster shot.
A third dose of Moderna's booster vaccine resulted in a 37-fold increase in antibody protection against the fast-spreading Omicron variant.
Moderna shared new data which shows that a 50 microgram dose of its booster vaccine increases the level of neutralizing antibodies 37-fold.
Two shots of J&J's vaccine yields fewer side effects than three shots of Pfizer or Moderna, new CDC data shows.
At least 75 federal lawmakers held shares of the COVID-19 vaccine makers Moderna, Johnson & Johnson, or Pfizer in 2020, an Insider analysis found.
A COVID-19 booster shot helps increase protection against the more contagious Omicron variant, Dr. Fauci said.
Next Page »